DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC

Alternative treatment modalities are necessary because of the low response rates and unsuitability of molecular-targeted agents (MTA) and/or immune checkpoint inhibitors (iCIs) in HCC patients. Therefore, we analyzed whether drug-eluting beads (DEB)-transcatheter arterial chemoembolization (TACE) wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Yasuteru, Morosawa, Tatsuki, Minami, Soichiro, Tanaka, Yasuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547057/
https://www.ncbi.nlm.nih.gov/pubmed/36207618
http://dx.doi.org/10.1038/s41598-022-21472-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547057/
https://www.ncbi.nlm.nih.gov/pubmed/36207618
http://dx.doi.org/10.1038/s41598-022-21472-1

Ejemplares similares